Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479765
Status:
TERMINATED
Last Update Posted:
2022-06-22
First Post:
2007-05-24
Brief Title:
A Phase 1 2 Dose Escalation Study of Locally-Administered OncoGel in Subjects With Recurrent Glioma
Sponsor:
Boston Scientific Corporation
Organization:
Boston Scientific Corporation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Brain Neoplasms |
| Glioblastoma Multiforme |